Allogeneic stem cell transplantation in follicular lymphoma. - Wikidata - wikimedia - TriplyDB

Allogeneic stem cell transplantation in follicular lymphoma.

Allogeneic stem cell transplantation in follicular lymphoma.

http://www.wikidata.org/entity/Q37887151

about

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma.Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders.Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

P2860

Q35151998-A238FDC4-D280-4624-A9F9-EFDF92DF741D Q36336614-2D338542-D35E-4D2F-B0D5-CEF9A932A915 Q36837761-8BF6C8C8-D43C-4E23-B2C4-4ABECD6FB904 Q36928725-9E63354A-218F-4E3F-9E46-484E139C14E8 Q37212916-70C17C62-9152-4A16-996F-2BD244713507

P2860

Allogeneic stem cell transplantation in follicular lymphoma.

http://www.wikidata.org/entity/Q37887151

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Allogeneic stem cell transplantation in follicular lymphoma.

@en

Allogeneic stem cell transplantation in follicular lymphoma.

@nl

type

label

Allogeneic stem cell transplantation in follicular lymphoma.

@en

Allogeneic stem cell transplantation in follicular lymphoma.

@nl

prefLabel

Allogeneic stem cell transplantation in follicular lymphoma.

@en

Allogeneic stem cell transplantation in follicular lymphoma.

@nl

P1433

Q37887151-7F5F82FC-A87C-40FD-8A6D-1CBCD49753F1

P1476

Q37887151-1AD19E90-45DC-4571-AED9-7F59D4BEE0CC

P2093

Q37887151-2CF6DAF5-3EAF-4D2A-8843-05B66419A6B5

P2860

Q37887151-19BB64C7-C10A-44F2-BD2C-0C4D06346B49

Q37887151-30216C2B-D7A8-4FBF-BAB0-F3F326F1BD38

Q37887151-31BF0DD1-A907-4867-8494-B29F3D685D6B

Q37887151-3791D91B-C072-463E-B5A9-2EA6AD50D6EB

Q37887151-3F04DB17-F4FD-4A29-BA5F-6AA53370380F

Q37887151-4846D50F-CE0A-45EC-902A-9AA7325A7C87

Q37887151-5B80F51B-23E8-4244-9546-A47F1B6FCD8D

Q37887151-5BD2ED45-42AD-4D89-A604-4EA471B83109

Q37887151-6D91FA60-DD72-4146-BC68-C4BA4FCA1F8C

Q37887151-8207D5A0-BEB8-48FC-8CAC-62A2C1025BA2

P304

Q37887151-F76F4794-E726-412E-ABD3-AC8FFECDEBD4

P31

Q37887151-D69B70A4-7975-4D79-AA23-324BAA87A4FC

P356

Q37887151-35558821-84B0-4BF1-B546-5EA4898FBF14

P433

Q37887151-FE7EFCB4-F6B9-4677-8322-97C6E2F7EEC9

P478

Q37887151-5B42CFDE-103B-43CD-8287-28199CDBF9F2

P577

Q37887151-C80337F8-242D-4A2F-9FEC-B63D26A80D98

P698

Q37887151-601EB45B-2A68-45DE-AE65-C9440CBA67CB

P932

Q37887151-86EE5513-5661-4C2E-B9BA-D0FA48BD7C15

P356

J.BEHA.2011.03.008

P1433

Best Practice and Research: Clinical Haematology

P1476

Allogeneic stem cell transplantation in follicular lymphoma.

@en

P2093

Issa F Khouri

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

New treatment options have changed the survival of patients with follicular lymphoma.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.

P304

271-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BEHA.2011.03.008

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21658623

http://www.w3.org/2001/XMLSchema#string

P932

4371582

http://www.w3.org/2001/XMLSchema#string